These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37461993)

  • 21. Systematic review and meta-analysis of the incidence and prevalence and 30-year trend of inflammatory bowel diseases in Asia: a study protocol.
    Safarpour AR; Mehrabi M; Keshtkar A; Edjtehadi F; Bagheri Lankarani K
    BMJ Open; 2019 Nov; 9(11):e031854. PubMed ID: 31748306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer.
    Choi CH; Ignjatovic-Wilson A; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Rutter MD; Graham TA; Hart AL
    Am J Gastroenterol; 2015 Oct; 110(10):1461-71; quiz 1472. PubMed ID: 26416190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Appendicectomy in Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Welsh S; Sam Z; Seenan JP; Nicholson GA
    Inflamm Bowel Dis; 2023 Apr; 29(4):633-646. PubMed ID: 35766795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies.
    Tsai L; Nguyen NH; Ma C; Prokop LJ; Sandborn WJ; Singh S
    Dig Dis Sci; 2022 Jun; 67(6):2451-2461. PubMed ID: 34379220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia.
    Cremer A; Demetter P; De Vos M; Rahier JF; Baert F; Moreels T; Macken E; Louis E; Ferdinande L; Fervaille C; Dedeurwaerdere F; Bletard N; Driessen A; De Hertogh G; Vermeire S; Franchimont D;
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1528-1536.e5. PubMed ID: 31202983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn's Disease in the Biologic Era: An Updated Systematic Review with Meta-analysis.
    Jew M; Meserve J; Eisenstein S; Jairath V; McCurdy J; Singh S
    J Crohns Colitis; 2024 Mar; 18(3):375-391. PubMed ID: 37707480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer risk of flat low-grade dysplasia in inflammatory bowel disease: a systematic review and proportion meta-analysis.
    Lauricella S; Fabris S; Sylla P
    Surg Endosc; 2023 Jan; 37(1):48-61. PubMed ID: 35920906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
    Qiu X; Ma J; Wang K; Zhang H
    Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies.
    Rozich JJ; Dulai PS; Fumery M; Sandborn WJ; Singh S
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2437-2447.e6. PubMed ID: 32142940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Cancers in Patients with Pediatric Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    Komaki Y; Komaki F; Yamada A; Micic D; Ido A; Sakuraba A
    J Pediatr; 2021 Feb; 229():102-117.e36. PubMed ID: 32898579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease.
    Selinger CP; Andrews JM; Titman A; Norton I; Jones DB; McDonald C; Barr G; Selby W; Leong RW;
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):644-50. PubMed ID: 23707778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
    Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
    Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of biological interventions for ulcerative colitis on health-related quality of life.
    LeBlanc K; Mosli MH; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD008655. PubMed ID: 26393522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials.
    Ben-Horin S; Novack L; Mao R; Guo J; Zhao Y; Sergienko R; Zhang J; Kobayashi T; Hibi T; Chowers Y; Peyrin-Biroulet L; Colombel JF; Kaplan GG; Chen MH
    Gastroenterology; 2022 Feb; 162(2):482-494. PubMed ID: 34757139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review with meta-analysis: IBD-associated colonic dysplasia prognosis in the videoendoscopic era (1990 to present).
    Kabir M; Fofaria R; Arebi N; Bassett P; Tozer PJ; Hart AL; Thomas-Gibson S; Humphries A; Suzuki N; Saunders B; Warusavitarne J; Faiz O; Wilson A
    Aliment Pharmacol Ther; 2020 Jul; 52(1):5-19. PubMed ID: 32432797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug utilization of biologic therapy in Crohn's disease and ulcerative colitis: a population-based Danish cohort study 2015-2020.
    Jensen KJ; Jensen CB; Wennerström C; Burisch J; Petersen J
    Scand J Gastroenterol; 2023 Jul; 58(7):726-736. PubMed ID: 36802972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.